Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3999353 | Urologic Oncology: Seminars and Original Investigations | 2016 | 5 Pages |
Abstract
Although most programs have guidelines on PSA screening in renal transplantation candidates, there is still variation nationwide in screening and treatment practices. AS is a viable treatment option in most of the programs. Our results suggest a benefit of a consensus panel to recommend guidelines in this population.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Greg E. M.D., Jorge F. M.D., Alan D. M.S., Reza M.D., Susan M. M.D., John P. M.D., Courtney K. M.D.,